(S)-(-)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol - CAS 112068-01-6
Catalog: |
BB002863 |
Product Name: |
(S)-(-)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol |
CAS: |
112068-01-6 |
Synonyms: |
diphenyl-[(2S)-2-pyrrolidinyl]methanol; diphenyl-[(2S)-pyrrolidin-2-yl]methanol |
IUPAC Name: | diphenyl-[(2S)-pyrrolidin-2-yl]methanol |
Description: | (S)-(-)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol (CAS# 112068-01-6 ) is a useful research chemical. |
Molecular Weight: | 253.34 |
Molecular Formula: | C17H19NO |
Canonical SMILES: | C1CC(NC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O |
InChI: | InChI=1S/C17H19NO/c19-17(16-12-7-13-18-16,14-8-3-1-4-9-14)15-10-5-2-6-11-15/h1-6,8-11,16,18-19H,7,12-13H2/t16-/m0/s1 |
InChI Key: | OGCGXUGBDJGFFY-INIZCTEOSA-N |
Boiling Point: | 411.3 °C at 760 mmHg |
Melting Point: | 77-80 °C |
Purity: | 99 % |
Density: | 1.128 g/cm3 |
Solubility: | Soluble in chloroform. |
Appearance: | Powder or crystals |
Storage: | Room temperature. |
MDL: | MFCD00075506 |
LogP: | 3.00330 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-11110444-B2 | Chiral catalyst and heterogeneous chiral catalyst comprising the same | 20191230 |
US-2021197182-A1 | Chiral catalyst and heterogeneous chiral catalyst comprising the same | 20191230 |
WO-2021032088-A1 | Method for preparing l-erythrobiopterin compound | 20190819 |
WO-2020254509-A1 | Drug combination for use in the treatment of inflammatory diseases | 20190618 |
CN-110157766-B | Preparation method of (1R,2S) -2- (3, 4-difluorophenyl) cyclopropylamine | 20190613 |
PMID | Publication Date | Title | Journal |
22687464 | 20121203 | 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review | Progress in neuro-psychopharmacology & biological psychiatry |
22882169 | 20120901 | Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP) | Clinical toxicology (Philadelphia, Pa.) |
22248120 | 20120101 | 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist | Clinical toxicology (Philadelphia, Pa.) |
22053986 | 20111202 | Noncovalent organocatalysis: a powerful tool for the nucleophilic epoxidation of α-ylideneoxindoles | Organic letters |
21970769 | 20111001 | Clinical toxicology of newer recreational drugs | Clinical toxicology (Philadelphia, Pa.) |
Complexity: | 261 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 253.146664230 |
Formal Charge: | 0 |
Heavy Atom Count: | 19 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 253.146664230 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 32.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS